Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARE: Spironolactone vs Amiloride in Resistant Hypertension
NCT04331691Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Nov 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiloride in resistant hypertension (RH), sponsored by Yonsei University. Started Nov 2020; status: completed.
02
Drugs
amiloride
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT04331691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331691.